title: Impairment of Brucella growth in human macrophagic cells that produce nitric oxide.
abstract: In mice, nitric oxide (NO) production by inducible NO synthase (iNOS), is a component of the control of Brucella infection. In humans, the involvement of iNOS in infection is still a matter of debate. Based on in vitro experiments, it was recently postulated that in humans, Brucella infection tends to become chronic because NO cannot exert its deleterious effect. In fact, conditions allowing NO production by human macrophages in culture are poorly defined, rendering the in vitro study of NO function difficult. Using DFGiNOS U937 macrophagic cells engineered to produce NO and U937 cells activated by ligation of IgE receptors, we showed that the intracellular development of Brucella was impaired in human macrophages, which produced NO. Although Brucella-infected human macrophagic phagocytes did not release NO in commonly used models of infection, the machinery required to produce NO was expressed in these cells and could be triggered by cell membrane receptors present on the infected cells. Therefore, the lack of NO production in isolated human macrophages infected by Brucella under in vitro conditions did not exclude a possible involvement of NO in the control of human brucellosis.
authors.affiliation: INSERM U-431, University of Montpellier II, Place E. Bataillon, Montpellier 34095, France.
authors.forename: Antoine
authors.initials: A
authors.lastname: Gross
authors.forename: Sylvie
authors.initials: S
authors.lastname: Bertholet
authors.forename: Jacques
authors.initials: J
authors.lastname: Mauel
authors.forename: Jacques
authors.initials: J
authors.lastname: Dornand
mesh_terms: D002002:Brucella / Q000254:growth & development* / Q000472:pathogenicity*; D002460:Cell Line; D015169:Colony Count, Microbial; D005786:Gene Expression Regulation; D006131:Growth Inhibitors / Q000096:biosynthesis / Q000494:pharmacology; D006801:Humans; D007700:Kinetics; D008262:Macrophage Activation; D008264:Macrophages / Q000201:enzymology / Q000378:metabolism* / Q000382:microbiology*; D009569:Nitric Oxide / Q000096:biosynthesis* / Q000494:pharmacology; D019001:Nitric Oxide Synthase / Q000096:biosynthesis / Q000235:genetics; D052247:Nitric Oxide Synthase Type II; D009573:Nitrites / Q000032:analysis; D012333:RNA, Messenger / Q000032:analysis / Q000096:biosynthesis; D017455:Receptors, IgE / Q000502:physiology; D014162:Transfection; D020298:U937 Cells
chemical_list: D006131:Growth Inhibitors; D009573:Nitrites; D012333:RNA, Messenger; D017455:Receptors, IgE; D009569:Nitric Oxide; C496319:NOS2 protein, human; D019001:Nitric Oxide Synthase; D052247:Nitric Oxide Synthase Type II